|
Pons JA, Revilla Nuin B, Ramírez P, Baroja Mazo A, Martínez Alarcón L, Robles R, Sánchez Bueno F, Rios A, Cascales Campos P, Parrilla P. What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation? Transplant Proc. 2012 Jul-Aug;44(6):1530-2. doi: 10.1016/j.transproceed.2012.05.026. Review. PubMed PMID: 22841204.
AÑO: 2012; IF: 0.952
|
22841204
|
Compan V, Baroja-Mazo A, Bragg L, Verkhratsky A, Perroy J, Pelegrin P. A genetically encoded IL-1? bioluminescence resonance energy transfer sensor to monitor inflammasome activity. J Immunol. 2012 Sep 1;189(5):2131-7. doi: 10.4049/jimmunol.1201349. Epub 2012 Jul 18. PubMed PMID: 22815289; PubMed Central PMCID: PMC3437522.
AÑO: 2012; IF: 5.52
|
|
Barberà-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, Pelegrín P. P2X7 receptor-stimulation causes fever via PGE2 and IL-1? release. FASEB J. 2012 Jul;26(7):2951-62. doi: 10.1096/fj.12-205765. Epub 2012 Apr 6. PubMed PMID: 22490780.
AÑO: 2012; IF: 5.704
|
|
Baroja-Mazo A, Pelegrín P. Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates. J Osteoporos. 2012;2012:408242. doi: 10.1155/2012/408242. Epub 2012 Jul 8. PubMed PMID: 22830074; PubMed Central PMCID: PMC3399340.
AÑO: 2012
|
|
Baroja-Mazo A, Barberà-Cremades M, Pelegrín P. P2X7 receptor activation impairs exogenous MHC class I oligopeptides presentation in antigen presenting cells. PLoS One. 2013 Aug 5;8(8):e70577. doi: 10.1371/journal.pone.0070577. PubMed PMID: 23940597; PubMed Central PMCID: PMC3734297.
AÑO: 2013; IF: 3.534
|